What is the WHO recommended monitoring of tenofovir and entecavir toxicity in patients with hepatitis B (HBV) (Hep B) infection?

Updated: Jun 08, 2021
  • Author: Nikolaos T Pyrsopoulos, MD, PhD, MBA, FACP, AGAF; Chief Editor: BS Anand, MD  more...
  • Print

Before initiating antiviral therapy, consider measuring all individuals' baseline renal function as well as evaluating their baseline risk for renal dysfunction.

Monitor renal function every year in individuals on long-term tenofovir or entecavir therapy; carefully monitor growth in children.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!